Parker, Chris

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 3,408

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Dearnaley, D., Syndikus, I., Mossop, H., Khoo, V., Birtle, A., Bloomfield, D., Graham, J., Kirkbride, P., Logue, J., Malik, Z., et al. (2016) · The Lancet Oncology

Prostate Cancer Diagnosis and TreatmentAdvanced Radiotherapy Techniques

Cited by 1,339

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Parker, C., Castro, E., Fizazi, K., Heidenreich, A., Ost, P., Procopio, G., Tombal, B., & Gillessen, S. (2020) · Annals of Oncology

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research

Cited by 977

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

Vergis, R., Corbishley, C. M., Norman, A. R., Bartlett, J., Jhavar, S., Borre, M., Heeboll, S., Horwich, A., Huddart, R., Khoo, V., et al. (2008) · The Lancet Oncology

Prostate Cancer Diagnosis and TreatmentCancer, Hypoxia, and Metabolism

Cited by 282

PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

Ferraldeschi, R., Nava Rodrigues, D., Riisnaes, R., Miranda, S., Figueiredo, I., Rescigno, P., Ravi, P., Pezaro, C., Omlin, A., Lorente, D., et al. (2015) · European Urology

Prostate Cancer Treatment and ResearchPI3K/AKT/mTOR signaling in cancer

Cited by 268

Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021

Gillessen, S., Armstrong, A., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., Bossi, A., Briganti, A., Bristow, R. G., Bulbul, M., et al. (2022) · European Urology

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 130

3381: Primary endpoint analysis of TRAP, first prospective Phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303)

Patel, P., Dreibe, S., Attard, G., Cole, A. J., Frew, J., Guevara, J., Mullassery, V., Murray, J., Parker, C., Palaniappan, N., et al. (2024) · Radiotherapy and Oncology

Prostate Cancer Diagnosis and TreatmentAdvanced Radiotherapy Techniques

Cited by 4